ALFA Finder| Value | ₹78.13 Cr |
|---|
NSE filing, NSE: GANDHITUBE. Summary written from the filing by ALFA Finder's alert engine.
Gandhi Special Tubes Ltd: key numbers
- Share price
- ₹914.10
- Market cap
- ₹1,111 Cr
- Revenue (annual)
- ₹191.8 Cr
- Net profit (annual)
- ₹68.36 Cr
- P/E (TTM)
- 14.4×Sector 17.1×
- Promoter holding
- 71.70%-1.83% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gandhi Special Tubes Ltd
All →Gandhi Special Tubes Q2 FY27 Results: Net Profit ₹19.9 Cr, Up 12.4% YoY
Gandhi Special Tubes Ltd reported revenue from operations of ₹58.1 Cr (+21.0% YoY) and net profit of ₹19.9 Cr (+12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹19.9 Cr · +12.4% YoY
Gandhi Special Tubes Board Meeting Date
Gandhi Special Tubes intimated that its Board meeting is scheduled for 3 November 2026 to consider Q2 and half-year unaudited financial results. Trading window remains closed until results are published.
Gandhi Special Tubes Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
Gandhi Special Tubes Price Movement Clarification
Gandhi Special Tubes replied to NSE's volume-spurt query stating all price-sensitive information is disclosed. It attributes the trading surge purely to market conditions with no pending announcements.
Gandhi Special Tubes Other Announcement
Gandhi Special Tubes Ltd filed its quarterly shareholding pattern as per SEBI regulations, detailing the distribution of equity shares among promoters and public shareholders.
Gandhi Special Tubes Capital Structure Change
Gandhi Special Tubes Limited concluded its buyback of 8,68,100 equity shares at Rs. 900 per share, totalling Rs. 78.13 Crore.
- Value
- ₹78.13 Cr
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring Worth ₹9.38 Cr
Zydus Lifesciences completed its ₹9.38 Crore 50% subscription in JV Zydus Sunshine Lifesciences. The transaction with Sunshine Healthcare Lanka was fully executed on November 11, 2026.
- Value
- ₹9.38 Cr
Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.